Cookie Settings
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Other cookies are those that are being identified and have not been classified into any category as yet.

No cookies to display.

Issue of share options and PDMR dealing

Science Group plc (AIM:SAG) announces that on 22 August 2024 the Company granted options (“EEI Options”) over 1,200,000 ordinary shares in its share capital to 12 employees of the group under the Enhanced Executive Incentive Addendum to the Company’s Performance Share Plan.  This grant of EEI Options was approved by shareholders at the Company’s Annual General Meeting on 18 June 2024.  The EEI Options will vest after five years from the date of issue and are exercisable at the nominal value of the share of 1 pence per share for a period of five years from vesting, provided that certain share price targets have been met. 

Details of Director and other PDMR option awards are included in the disclosure notices below.  Save for the below, the Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.

Read more about us

Investor informationarrow pointing right

Key investor information and corporate governance

Financial reports

View our financial reports and presentations

Contact us

By submitting your details you agree to us holding the personal data you've supplied for the purpose of processing your enquiry. For information about how we handle your data, please read our privacy policy